Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal
Table 2 from Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar
Serum free light chain assessment in monoclonal gammopathy and kidney disease | Nature Reviews Nephrology
Excluding myeloma diagnosis using revised thresholds for serum free light chain ratios and M-protein levels | Haematologica
Following & Understanding Your Free Light Chain Test Results - YouTube
Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies - ScienceDirect
Providence Health Care Test Catalog
Comparison of serum free light chain and urine electrophoresis for the detection of the light chain component of monoclonal immunoglobulins in light chain and intact immunoglobulin multiple myeloma | Haematologica
Familial Myeloma | NEJM
Ο χρήστης Manni Mohyuddin στο Twitter: "So some basics first- As immunoglobulins are made by normal plasma cells, free light chains are produced in excess of heavy light chains and spilled over